Tag: anaphylaxis

All

FDA Approves First Epinephrine Nasal Spray for Anaphylaxis

The epinephrine nasal spray provides a needle-free option for rapid emergency treatment of severe allergic reactions.

Two-Thirds of Children Tolerate Peanut Protein After Omalizumab Treatment
FDA Approves Xolair as First Drug to Treat Food Allergies
Neffy Epinephrine Nasal Spray Proves Effective in Anaphylaxis
New Guidelines for Treating Anaphylaxis and Atopic Dermatitis
Early Food Allergy Tied to Asthma and Lung Health Issues in Childhood
‘Allergic March’ Validated in New Pediatric Allergy Research
Emergency Room Anaphylaxis Observation Times Could Be Halved

All

Researchers Discover Potential Way to Block Peanut Allergy Anaphylaxis

Researchers from Indiana University School of Medicine say the discovery could lead to life-saving therapeutics for people with severe peanut allergies.

86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
Half of Adults with Severe Food Allergy Prescribed Epinephrine Pen
Syringes of Symjepi Epinephrine Recalled
FDA Approves Naloxone Auto-Injector for Exposure to Ultra-Potent Weaponized Opioids
ACAAI Updates Guidance on Allergic Reactions to COVID-19 Vaccine
Evzio Naloxone Auto-injector and Generic Discontinued

All

Immune Cell Subtype May Drive Allergic Reactions

Scientists have identified a subtype of immune cells called Tfh13 that drives the production of antibodies associated with anaphylaxis and other allergic reactions.

Anaphylaxis Triggered by Amoxicillin in Semen
Positive Data for Epinephrine Nasal Spray for Anaphylaxis
Why Allergic Shock Happens so Rapidly
First Generic EpiPen Approved by FDA
FDA Approves Epinephrine Auto-injector for Small Children
First Case of Severe Allergic Reaction to Orange

Tag: anaphylaxis

All

FDA Approves First Epinephrine Nasal Spray for Anaphylaxis

Two-Thirds of Children Tolerate Peanut Protein After Omalizumab Treatment

FDA Approves Xolair as First Drug to Treat Food Allergies

Neffy Epinephrine Nasal Spray Proves Effective in Anaphylaxis

New Guidelines for Treating Anaphylaxis and Atopic Dermatitis

Early Food Allergy Tied to Asthma and Lung Health Issues in Childhood

‘Allergic March’ Validated in New Pediatric Allergy Research

Emergency Room Anaphylaxis Observation Times Could Be Halved

All

Researchers Discover Potential Way to Block Peanut Allergy Anaphylaxis

86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine

Half of Adults with Severe Food Allergy Prescribed Epinephrine Pen

Syringes of Symjepi Epinephrine Recalled

FDA Approves Naloxone Auto-Injector for Exposure to Ultra-Potent Weaponized Opioids

ACAAI Updates Guidance on Allergic Reactions to COVID-19 Vaccine

Evzio Naloxone Auto-injector and Generic Discontinued

All

Immune Cell Subtype May Drive Allergic Reactions

Anaphylaxis Triggered by Amoxicillin in Semen

Positive Data for Epinephrine Nasal Spray for Anaphylaxis

Why Allergic Shock Happens so Rapidly

First Generic EpiPen Approved by FDA

FDA Approves Epinephrine Auto-injector for Small Children

First Case of Severe Allergic Reaction to Orange

Sorry, No Posts Found

Respiratory Therapy

Our Parent Company

Key Resources

Helpful Links